The discussion paper on compulsory licensing of patents will have achieved its purpose if it can lead to a proactive policy in the area of drugs and health. IN a proactive move to ensure a fair balance between protection of intellectual property rights and protection of the public interest, the Department of Industrial Policy and Promotion (DIPP) of the Ministry of Commerce and Industry has chosen to put out a discussion...
More »SEARCH RESULT
Trade Talks with EU Put Drug Manufacturers on Edge by Keya Acharya
Their ongoing negotiations remain shrouded in secrecy, but there are already reports that India and the European Union (EU) will have a free-trade agreement ready by the end of August, and that they will be putting signatures to it before the end of 2010. Yet it is a potential development that is causing more nervous chatter than joyous jitters here in India, where drug manufacturers in particular have raised concerns over...
More »Three firms rank highest on access to poor by Donald G. Mcneil Jr
GlaxoSmithKline, Merck and Novartis have taken the top three spots again on the Access to Medicine Index, which ranks pharmaceutical companies on how readily they make their products available to the world's poor. It was the second time the rankings, which were created in 2008, have been issued. This time, 95 per cent of the brand-name companies approached by the Dutch foundation that started the index agreed to provide information;...
More »Medicines bought in bulk by govt can help cut costs by Subodh Varma
By spending just Rs 6,000 crore, the government can make a huge dent in the treatment of all sick people across the whole country — currently, people are spending as much as Rs 25,000 crore on buying essential medicines. This was the strong message sent out from a National Consultation organized by several civil society groups at New Delhi on Tuesday. Officials of the health ministry and the Planning Commission...
More »Will India-EU deal make drugs dearer? by Rema Nagarajan
Is the Indian government bargaining away the rights of millions across the world to essential drugs supplied by India, hailed as the pharmacy of the developing world, in the name of free trade with the European Union (EU)? That's a fear being expressed by civil society groups in the developing world. Commerce minister Anand Sharma vehemently denies such a possibility, claiming that the free trade agreement (FTA) under negotiation with...
More »